Health Catalyst upgraded to Overweight from Sector Weight at KeyBanc

KeyBanc last night upgraded Health Catalyst (HCAT) to Overweight from Sector Weight with a $9 price target The firm says “sustained healthy” utilization levels from its credit card data should bode well for hospital technology budgets. Health Catalyst is in the early stages of “healthy” margin expansion into “healthier” technology revenue growth and the shares trade at “deeply discounted valuation,” the analyst tells investors in a research note.